Argent Capital Management LLC Buys 6,555 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Argent Capital Management LLC increased its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 16.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 45,812 shares of the company’s stock after purchasing an additional 6,555 shares during the period. Argent Capital Management LLC owned approximately 0.25% of Addus HomeCare worth $5,743,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of ADUS. Connor Clark & Lunn Investment Management Ltd. bought a new position in Addus HomeCare in the 3rd quarter valued at about $1,622,000. Dimensional Fund Advisors LP lifted its stake in Addus HomeCare by 0.8% during the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after purchasing an additional 5,421 shares during the last quarter. Point72 Asset Management L.P. increased its stake in shares of Addus HomeCare by 73.4% in the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after purchasing an additional 315,602 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Addus HomeCare by 10.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company’s stock valued at $24,371,000 after purchasing an additional 16,997 shares during the last quarter. Finally, American Century Companies Inc. increased its holdings in shares of Addus HomeCare by 90.6% during the second quarter. American Century Companies Inc. now owns 18,393 shares of the company’s stock worth $2,136,000 after buying an additional 8,743 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Stock Up 2.1 %

NASDAQ ADUS opened at $131.27 on Thursday. Addus HomeCare Co. has a 12-month low of $85.94 and a 12-month high of $136.12. The company’s 50 day moving average is $125.07 and its 200-day moving average is $126.29. The firm has a market cap of $2.38 billion, a P/E ratio of 30.04, a price-to-earnings-growth ratio of 2.11 and a beta of 1.00.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. During the same period in the prior year, the business posted $1.03 earnings per share. The company’s revenue was up 7.1% on a year-over-year basis. Equities analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current year.

Insider Transactions at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO R Dirk Allison sold 25,000 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the transaction, the chief executive officer now owns 79,397 shares in the company, valued at $9,905,569.72. This represents a 23.95 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 39,750 shares of company stock valued at $4,930,750. Insiders own 4.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. StockNews.com raised Addus HomeCare from a “hold” rating to a “buy” rating in a report on Wednesday, December 11th. Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a report on Thursday, November 14th. KeyCorp began coverage on Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 price objective on the stock. Finally, Macquarie restated an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a research report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, nine have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Addus HomeCare currently has an average rating of “Buy” and a consensus target price of $133.67.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.